Core Insights - Pacific Biosciences of California, Inc. (PACB) has partnered with DNAstack to create the first global federated dataset of HiFi whole genome sequencing data, aimed at enhancing rare disease research while ensuring data privacy compliance [1][2][4] Collaboration Details - The collaboration will utilize DNAstack's secure, cloud-enabled infrastructure, allowing institutions to connect their PacBio HiFi whole genome sequencing data without transferring sensitive datasets, thus enabling cross-border analysis while adhering to privacy regulations [3] - The HiFi Solves Global Consortium has expanded to nearly 30 institutions across 15 countries, linking over 10,000 HiFi whole genome sequences, which enhances statistical power for rare disease studies and streamlines workflows [4] Industry Prospects - The global long-read sequencing market is projected to grow from $538.9 million in 2024 to $1.53 billion by 2030, with a compound annual growth rate (CAGR) of 20.12% from 2025 to 2030, driven by the rising prevalence of genetic diseases [5] Other Developments - In January, PACB's HiFi whole-genome sequencing technology was adopted for a major research initiative on Sudden Unexplained Death in Childhood, and a new method called CiFi was introduced for chromosome-scale genome assemblies [6] Peer Updates - Illumina, Inc. has acquired SomaLogic for $350 million to enhance its multiomics ecosystem, while also launching TruPath Genome to improve genetic disease research capabilities [7][9]